GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orgenesis Inc (FRA:45O) » Definitions » Shiller PE Ratio

Orgenesis (FRA:45O) Shiller PE Ratio : (As of Sep. 22, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Orgenesis Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Orgenesis Shiller PE Ratio Historical Data

The historical data trend for Orgenesis's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orgenesis Shiller PE Ratio Chart

Orgenesis Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Orgenesis Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Orgenesis's Shiller PE Ratio

For the Biotechnology subindustry, Orgenesis's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orgenesis's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Orgenesis's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Orgenesis's Shiller PE Ratio falls into.



Orgenesis Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Orgenesis's E10 for the quarter that ended in Jun. 2024 is calculated as:

For example, Orgenesis's adjusted earnings per share data for the three months ended in Jun. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=-0.214/132.5538*132.5538
=-0.214

Current CPI (Jun. 2024) = 132.5538.

Orgenesis Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201408 -0.541 100.352 -0.715
201411 0.000 99.635 0.000
201502 -0.211 99.032 -0.282
201505 -0.322 100.333 -0.425
201508 -0.431 100.548 -0.568
201511 -0.224 100.135 -0.297
201602 0.011 100.040 0.015
201605 -0.424 101.355 -0.555
201608 -0.214 101.617 -0.279
201611 -0.538 101.829 -0.700
201702 -0.620 102.779 -0.800
201705 -0.235 103.256 -0.302
201708 -0.339 103.587 -0.434
201711 0.026 104.072 0.033
201802 -0.421 105.052 -0.531
201805 -0.169 106.148 -0.211
201808 -0.303 106.383 -0.378
201811 -0.343 106.338 -0.428
201903 -0.487 107.251 -0.602
201906 -0.319 108.070 -0.391
201909 -0.400 108.329 -0.489
201912 -0.378 108.420 -0.462
202003 3.828 108.902 4.659
202006 -0.844 108.767 -1.029
202009 -0.093 109.815 -0.112
202012 -1.866 109.897 -2.251
202103 -0.008 111.754 -0.009
202106 -0.091 114.631 -0.105
202109 -0.357 115.734 -0.409
202112 -0.177 117.630 -0.199
202203 -0.145 121.301 -0.158
202206 -0.208 125.017 -0.221
202209 -0.051 125.227 -0.054
202212 -0.151 125.222 -0.160
202303 -0.813 127.348 -0.846
202306 -0.701 128.729 -0.722
202309 -0.112 129.860 -0.114
202312 -0.193 129.419 -0.198
202403 -0.267 131.776 -0.269
202406 -0.214 132.554 -0.214

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Orgenesis  (FRA:45O) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Orgenesis Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Orgenesis's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Orgenesis Business Description

Traded in Other Exchanges
Address
20271 Goldenrod Lane, Germantown, MD, USA, 20876
Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). The Company's business includes two reporting segments: Morgenesis and Therapies.

Orgenesis Headlines

No Headlines